QOL

Cecilia BrownAggressive B-Cell Lymphoma | November 22, 2022
Axicabtagene ciloleucel, an autologous anti-CD19 CAR T-cell treatment, improved quality of life compared to standard of care ...
Leah LawrenceHodgkin Lymphoma | November 14, 2022
Long-term lymphoma survivors who underwent transplant had impaired health-related quality of life.
Advertisement
Advertisement
Advertisement
Advertisement